back
AstraZeneca PLC
AZN:XLON
 | |
| Total Impact: | $ 27.1B |
| Per $ of Revenue: | $ 0.59 |
| Industry: | Pharmaceuticals |
| Industry Group: | Pharmaceuticals, Biotechnology and Life Sciences |
| Country: | United Kingdom |
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company headquartered in Cambridge, United Kingdom. Formed in 1999 through the merger of Astra AB and Zeneca Group, AstraZeneca is a leading company in drug development, specializing in oncology, cardiovascular, renal, and respiratory treatments. It gained global recognition during the COVID-19 pandemic for developing one of the first vaccines against the virus. AstraZeneca is listed on the London Stock Exchange and NASDAQ, and is part of the FTSE 100 index.
Impacts by Stakeholders
Monetized impact in per $ of revenue
Total Impact by Year
Monetized impact in absolute $ terms
Company Impact
Industry Impact
*For more details visit our RIFT portal or write us on our Contact page.